These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24509954)

  • 1. New horizons: urinary incontinence in older people.
    Gibson W; Wagg A
    Age Ageing; 2014 Mar; 43(2):157-63. PubMed ID: 24509954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous targets for the treatment of bladder dysfunction.
    Yoshimura N; Miyazato M; Kitta T; Yoshikawa S
    Neurourol Urodyn; 2014 Jan; 33(1):59-66. PubMed ID: 23832777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating urinary incontinence in older women.
    Stewart E
    Br J Community Nurs; 2010 Nov; 15(11):526, 528, 530-2. PubMed ID: 21079556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
    Chen YC; Kuo HC
    Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expert panel recommendations on therapeutic and diagnostic management of urinary incontinence and overactive bladder in women].
    Radziszewski P; Baranowski W; Nowak-Markwitz E; Rechbeger T; Suzin J; Witek A;
    Ginekol Pol; 2010 Oct; 81(10):789-93. PubMed ID: 21117310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence.
    Wagg A; Gibson W; Ostaszkiewicz J; Johnson T; Markland A; Palmer MH; Kuchel G; Szonyi G; Kirschner-Hermanns R
    Neurourol Urodyn; 2015 Jun; 34(5):398-406. PubMed ID: 24700771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic modulation of urinary bladder function: multiple targets at multiple levels.
    Michel MC
    Annu Rev Pharmacol Toxicol; 2015; 55():269-87. PubMed ID: 25251997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-A.
    Kanai A; Wyndaele JJ; Andersson KE; Fry C; Ikeda Y; Zabbarova I; De Wachter S
    Neurourol Urodyn; 2011 Jun; 30(5):684-91. PubMed ID: 21661014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subject-controlled stimulation of dorsal genital nerve to treat neurogenic detrusor overactivity at home.
    Opisso E; Borau A; Rijkhoff NJ
    Neurourol Urodyn; 2013 Sep; 32(7):1004-9. PubMed ID: 23281007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability.
    Chapple CR; Cardozo L; Nitti VW; Siddiqui E; Michel MC
    Neurourol Urodyn; 2014 Jan; 33(1):17-30. PubMed ID: 24127366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.
    Gobeaux N; Yates DR; Denys P; Even-Schneider A; Richard F; Chartier-Kastler E
    Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary symptoms and urodynamic findings in women with pelvic organ prolapse: is there a correlation? Results of an artificial neural network analysis.
    Serati M; Salvatore S; Siesto G; Cattoni E; Braga A; Sorice P; Cromi A; Ghezzi F; Bolis P
    Eur Urol; 2011 Aug; 60(2):253-60. PubMed ID: 21420230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic management of bladder dysfunction in adult women.
    O'Dell K
    J Obstet Gynecol Neonatal Nurs; 2014; 43(2):253-63. PubMed ID: 24502427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of urinary incontinence, voiding dysfunction, and overactive bladder.
    Rahn DD; Roshanravan SM
    Obstet Gynecol Clin North Am; 2009 Sep; 36(3):463-74. PubMed ID: 19932410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "overactive bladder".
    Chapple C
    Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S6-13. PubMed ID: 25042142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms.
    Peters KM; Killinger KA; Boguslawski BM; Boura JA
    Neurourol Urodyn; 2010 Sep; 29(7):1267-71. PubMed ID: 19787710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes.
    Lin TL; Chen GD; Chen YC; Huang CN; Ng SC
    Taiwan J Obstet Gynecol; 2012 Sep; 51(3):381-6. PubMed ID: 23040921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "Rectal distension: the effect on bladder function".
    De Wachter S
    Neurourol Urodyn; 2011 Mar; 30(3):353. PubMed ID: 20886572
    [No Abstract]   [Full Text] [Related]  

  • 20. Detrusor underactivity: Clinical features and pathogenesis of an underdiagnosed geriatric condition.
    Taylor JA; Kuchel GA
    J Am Geriatr Soc; 2006 Dec; 54(12):1920-32. PubMed ID: 17198500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.